Clinical Nuclear Medicine

Skip Navigation LinksHome > February 2014 - Volume 39 - Issue 2 > Potential Role of FDG PET/CT in Evaluating Patients With Hep...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0000000000000312
Review Article

Potential Role of FDG PET/CT in Evaluating Patients With Hepatic Incidentalomas

Grassetto, Gaia MD*; Marzola, Maria Cristina MD*; Chondrogiannis, Sotirios MD*; Maffione, Anna Margherita MD*; Rampin, Lucia MD*; Galeotti, Fabrizio MD; Colletti, Patrick M. MD; Rubello, Domenico MD*

Collapse Box


Abstract: This review article is focused on the role of FDG PET/CT in diagnosing and characterizing hepatic incidentalomas. A large variety of unsuspected lesions can be detected in the liver both with ultrasound and CT performed for other reasons; the prevalence of liver incidentalomas increases in patients with chronic liver disease or preexisting oncologic history. The major challenge is to discriminate benign from malignant lesions. There is a large body of literature indicating that FDG PET/CT is a useful tool to this purpose even if it is unspecific (ie, it cannot differentiate a primary tumor from a secondary lesion). Occasionally, FDG PET/CT can be useful for biopsy guidance.

© 2014 by Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.